drugset / Trial / NCT00886925

Efficacy of Albumin for Acute Encephalopathy in Patients With Cirrhosis

NCT00886925

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine whether the administration of albumin in addition to the standard care is effective in the treatment of an episode of hepatic encephalopathy in patients with cirrhosis.

Timeline

Start
2009-03
Primary completion
2012-07
Completion
2012-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator Albumin Protein / enzyme biologic 1 g/kg Intravenous